JP2016521684A5 - - Google Patents

Download PDF

Info

Publication number
JP2016521684A5
JP2016521684A5 JP2016515094A JP2016515094A JP2016521684A5 JP 2016521684 A5 JP2016521684 A5 JP 2016521684A5 JP 2016515094 A JP2016515094 A JP 2016515094A JP 2016515094 A JP2016515094 A JP 2016515094A JP 2016521684 A5 JP2016521684 A5 JP 2016521684A5
Authority
JP
Japan
Prior art keywords
solution
hypochlorous acid
magnesium
amount
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016515094A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016521684A (ja
JP6416227B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/039202 external-priority patent/WO2014190184A1/en
Publication of JP2016521684A publication Critical patent/JP2016521684A/ja
Publication of JP2016521684A5 publication Critical patent/JP2016521684A5/ja
Application granted granted Critical
Publication of JP6416227B2 publication Critical patent/JP6416227B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016515094A 2013-05-22 2014-05-22 安定化次亜塩素酸溶液及びその使用 Expired - Fee Related JP6416227B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361826382P 2013-05-22 2013-05-22
US61/826,382 2013-05-22
PCT/US2014/039202 WO2014190184A1 (en) 2013-05-22 2014-05-22 Stabilized hypochlorous acid solution and use thereof

Publications (3)

Publication Number Publication Date
JP2016521684A JP2016521684A (ja) 2016-07-25
JP2016521684A5 true JP2016521684A5 (enExample) 2017-06-29
JP6416227B2 JP6416227B2 (ja) 2018-10-31

Family

ID=51934166

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016515094A Expired - Fee Related JP6416227B2 (ja) 2013-05-22 2014-05-22 安定化次亜塩素酸溶液及びその使用

Country Status (6)

Country Link
US (2) US9918477B2 (enExample)
EP (1) EP2999341B1 (enExample)
JP (1) JP6416227B2 (enExample)
CA (1) CA2913137A1 (enExample)
MX (1) MX373524B (enExample)
WO (1) WO2014190184A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007085018A2 (en) 2006-01-20 2007-07-26 Oculus Innovative Sciences, Inc. Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution
MX373524B (es) * 2013-05-22 2020-04-21 Sanfer Farma S A P I De C V Solución estabilizada de ácido hipocloroso y uso de la misma.
KR20200034722A (ko) 2017-06-28 2020-03-31 콜리디온, 인코포레이티드 세척, 소독 및/또는 살균을 위한 조성물, 방법 및 용도
WO2019140408A1 (en) 2018-01-14 2019-07-18 Collidion, Inc. Compositions, kits, methods and uses for cleaning, disinfecting, sterilizing and/or treating
EP3927351A4 (en) 2019-02-20 2023-01-04 Biiosmart Technologies LLC INTRAVENOUS HYPOCHLOROUS ACID SOLUTION, PREPARATION AND METHOD OF USE
LU101842B1 (en) 2020-06-08 2021-12-08 Arnaud Mainnemare Pharmaceutical Composition for treating or preventing lesions and infections in a mammal
US11097945B1 (en) 2020-11-04 2021-08-24 Cougar Creek Electrolysed Water, Llc Methods and systems for production of an aqueous hypochlorous acid solution
IT202000028082A1 (it) 2020-11-23 2022-05-23 Md Italy Srl Composizione, preparazione ed impiego di una miscela a base di bromo per l’igiene perioculare, il trattamento e la prevenzione delle blefariti

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1236398A4 (en) * 1999-12-10 2004-04-07 Kao Corp MICROBICIDAL COMPOSITIONS
JP3554749B2 (ja) * 2001-02-22 2004-08-18 株式会社アクシス 殺菌消毒剤
US9168318B2 (en) 2003-12-30 2015-10-27 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and methods of using the same
US20050139808A1 (en) 2003-12-30 2005-06-30 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and process for producing same
US20050196462A1 (en) 2003-12-30 2005-09-08 Oculus Innovative Sciences, Inc. Topical formulation containing oxidative reductive potential water solution and method for using same
EP1702161A2 (en) 2003-12-30 2006-09-20 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution, processes for producing same and methods of using the same
CN101163491B (zh) 2005-03-23 2017-04-19 奥古露丝创新科学公司 利用氧化还原电位水溶液治疗皮肤溃疡的方法
AU2006226750B2 (en) 2005-03-23 2012-07-19 Oculus Innovative Sciences, Inc. Method of treating skin ulcers using oxidative reductive potential water solution
MX2007013774A (es) 2005-05-02 2008-01-29 Oculus Innovative Sciences Inc Metodo para utilizar solucion de agua con potencial oxido reductor en aplicaciones dentales.
WO2007085018A2 (en) * 2006-01-20 2007-07-26 Oculus Innovative Sciences, Inc. Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution
JP6099294B2 (ja) 2007-03-13 2017-03-22 オキュラス イノヴェイティヴ サイエンシズ、インコーポレイテッド 一酸化二塩素を含む抗菌溶液ならびにその製造方法および使用方法
CN102480972B (zh) * 2009-06-15 2014-12-10 奥古露丝创新科学公司 含有次氯酸的溶液及其使用方法
MX365380B (es) 2009-07-30 2019-05-31 Invekra S A P I De C V Formulacion de hidrogel que comprende agua con ppotencial de oxidacion-reduccion.
GB2488838A (en) * 2011-03-11 2012-09-12 Biomimetics Health Ind Ltd A stable antimicrobial aqueous hypochlorous acid solution
MX373524B (es) 2013-05-22 2020-04-21 Sanfer Farma S A P I De C V Solución estabilizada de ácido hipocloroso y uso de la misma.

Similar Documents

Publication Publication Date Title
JP2016521684A5 (enExample)
JP2012530142A5 (enExample)
JP2014515737A5 (enExample)
MX2020014000A (es) Formulaciones en lámina que contienen dexmedetomidina y métodos para producirlas.
MX2016006197A (es) Formulaciones de compuestos de azaindol.
RU2015126801A (ru) Фторид-стабильные цинкосодержащие композиции для ухода за полостью рта
JP2009523832A5 (enExample)
BRPI0409198A (pt) derivados quinolin-2-ona para o tratamento de doenças de vias aéreas
JP2010514799A5 (enExample)
RU2012155188A (ru) Композиции для ухода за полостью рта, устойчивые к микробному росту
BR112017007144A2 (pt) ácido valproico ou um sal farmaceuticamente aceitável do mesmo, composto, composição farmacêutica, e, composto ou composição para uso, uso, método ou composição.
CN104488957A (zh) 循环水系统用高效复合杀菌剂及其制备方法
MY161032A (en) Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate
NZ605860A (en) Use of vitamin c, and chromium-free vitamin k or 2-methyl-1,4-naphthalendione, and compositions thereof for treating a polycystic disease
PH12015501793A1 (en) Bicyclic compounds
MX389336B (es) Formulacion farmaceutica.
MX2015016057A (es) Solucion estabilizada de acido hipocloroso y uso de la misma.
WO2013086243A3 (en) Phospholipid compositions enriched for palmitoleic, myristoleic or lauroleic acid, their preparation and their use in treating metabolic and cardiovascular disease
BR112014004111A2 (pt) peneira molecular de silicoaluminofosfato e método de produção da mesma
JP2013509378A5 (enExample)
CN105410021A (zh) 一种无刺激日用消毒水
TW200745155A (en) Preparation of pharmaceutical salts of 3-O-(3',3'-dimethylsuccinyl)betulinic acid
NZ592378A (en) Choline and tromethamine salt of licofelone
WO2011048589A3 (en) Ion exchangers and methods of use thereof
WO2012169849A3 (en) Eye-drop composition for preventing or treating ocular diseases